GB1474424A - Pharmaceutical composition for treating diabetic ketoacidosis - Google Patents

Pharmaceutical composition for treating diabetic ketoacidosis

Info

Publication number
GB1474424A
GB1474424A GB3366774A GB3366774A GB1474424A GB 1474424 A GB1474424 A GB 1474424A GB 3366774 A GB3366774 A GB 3366774A GB 3366774 A GB3366774 A GB 3366774A GB 1474424 A GB1474424 A GB 1474424A
Authority
GB
United Kingdom
Prior art keywords
diabetic ketoacidosis
pharmaceutical composition
treating diabetic
octanoylcarnitine
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3366774A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB1474424A publication Critical patent/GB1474424A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Abstract

1474424 Compositions containing (+)- octanoylcarnitine Y KAWASHIMA 30 July 1974 [26 Sept 1973] 33667/74 Heading A5B A pharmaceutical composition for the treatment of diabetic ketoacidosis comprises a pharmaceutically acceptable inert carrier or diluent, other than water alone, and (+)- octanoylcarnitine in an amount effective to treat diabetic ketoacidosis in a human patient. The composition may also contain local anaesthetic agents such as lidocain chloride and benzyl alcohol, and insulin.
GB3366774A 1973-09-26 1974-07-30 Pharmaceutical composition for treating diabetic ketoacidosis Expired GB1474424A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP48107613A JPS5058213A (en) 1973-09-26 1973-09-26

Publications (1)

Publication Number Publication Date
GB1474424A true GB1474424A (en) 1977-05-25

Family

ID=14463599

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3366774A Expired GB1474424A (en) 1973-09-26 1974-07-30 Pharmaceutical composition for treating diabetic ketoacidosis

Country Status (5)

Country Link
US (1) US3929995A (en)
JP (1) JPS5058213A (en)
DE (1) DE2445801C2 (en)
FR (1) FR2244487B1 (en)
GB (1) GB1474424A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2230953A (en) * 1989-05-05 1990-11-07 Sigma Tau Ind Farmaceuti Compositions containing D-carnitine or an acyl derivative for the treatment of protozoal disease

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1143611B (en) * 1977-11-03 1986-10-22 Sigma Tau Ind Farmaceuti APPLICATION OF ACETYL-CARNITINE IN THE THERAPY OF CARDIAC AFFECTIONS OF / ANOXIC, ISCHEMIC, CARDIOTOXIC AND IN ARITHMIC SYNDROMES
IT1156741B (en) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti THERAPEUTIC APPLICATION OF CARNITINE AND SOME ACYLATED DERIVATIVES OF CARNITINE IN HEMODIALYSIS
IT1206954B (en) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti THERAPEUTIC AGENTS BASED ON AN ACIL DERIVATIVE OF CARNITINE FOR THE TREATMENT OF PERIPHERAL VASCULOPATHIES
IT1116037B (en) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti ACIL CARNITINE ESTERS AND AMIDS THEIR PREPARATION PROCEDURES AND THERAPEUTIC USE
IT1133010B (en) * 1980-05-15 1986-07-09 Sigma Tau Ind Farmaceuti THERAPUETIC METHOD FOR THE TREATMENT OF DIABETES AT YOUTH ONCE AND PHARMACEUTICAL COMPOSITION FOR THIS METHOD
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
US4731360A (en) * 1985-08-16 1988-03-15 Merck & Co., Inc. Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments
US10799564B1 (en) 2019-05-06 2020-10-13 Baxter International Inc. Insulin premix formulation and product, methods of preparing same, and methods of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624887A (en) * 1970-03-02 1971-12-07 Bunker Ramo Pin and socket removal tool

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2230953A (en) * 1989-05-05 1990-11-07 Sigma Tau Ind Farmaceuti Compositions containing D-carnitine or an acyl derivative for the treatment of protozoal disease
AP137A (en) * 1989-05-05 1991-08-05 Sigma Tau Ind Farmaceutiche Riunite Spa Pharmaceutical composition for the treatment of protozoal diseases particulary of trypanosomiasis, comprising D-carnitine or an acyl derivative of D-carnitine.
GB2230953B (en) * 1989-05-05 1993-03-24 Sigma Tau Ind Farmaceuti Compositions containing d-carnitine or an acyl derivative for the treatment of protozoal disease

Also Published As

Publication number Publication date
FR2244487A1 (en) 1975-04-18
JPS5058213A (en) 1975-05-21
DE2445801A1 (en) 1975-04-03
AU7226574A (en) 1975-05-01
US3929995A (en) 1975-12-30
DE2445801C2 (en) 1985-05-09
FR2244487B1 (en) 1978-06-30

Similar Documents

Publication Publication Date Title
IE862543L (en) Pharmaceutical compositions
UA41446C2 (en) Use of fumagilol or its derivatives for preparing drugs intended for treating intestinal infection and pharmaceutical composition
HUT51136A (en) Process for producing pharmaceutical compositions for treating schisophreny, containing l-deprenil as active component
HU9300541D0 (en) Ligand to receptor c-kit qnd method for its utilization
UA34419C2 (en) Lyophilised injectable preparation and method for tumour growth inhibition
EP0643775A4 (en) Therapeutic compositions.
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
DE69805983D1 (en) COUGH-RESISTANT COMPOSITIONS CONTAINING THEOBROMINE
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
ES478967A1 (en) 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds
GB1474424A (en) Pharmaceutical composition for treating diabetic ketoacidosis
AU580822B2 (en) New pyrrolobenzimidazoles, processes for the preparation thereof and pharmaceutical compositions containing them
MX9504023A (en) Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid.
ES8400076A1 (en) Tricyclic cytosine derivatives for use in pharmaceutical preparations and process for their preparation.
ES8503643A1 (en) Biscarboxamides for treating diseases, and process for their preparation.
IL112059A (en) Transdermal therapeutic composition containing a deuterated active substance with penetration-enhancing effect
HUT70531A (en) Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them
AU549890B2 (en) Para-substituted-3-phenoxy-1-alkoxycarbenyl-alkylamino- propanol-2 compounds
CA2108330A1 (en) Enhancer for the Antianemia Effect of Erythropoietin and Method of Augmenting the Antianemia Effect of Erythropoietin
GB1291266A (en) Material for the physiological treatment and refatting of human skin
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
ES449874A1 (en) Compound for the treatment of bovine mastitis
KR900017599A (en) Pharmaceutical composition for tumor treatment

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee